Search:
   

Friday, December 14, 2018

Equity Corporate Actions Alert #2018 - 236
(UPDATED) Information Regarding the Merger of Shire plc ADR (SHPG) and Takeda Pharmaceutical Company Limited

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:

At a special meeting held on December 5, 2018, shareholders of Shire plc (SHPG) approved the merger of the company with Takeda Pharmaceutical Company Limited. The merger became effective today, Tuesday, January 8, 2019.

Please note: Shire shares were suspended on the London Stock Exchange before the open of business on January 7, 2019. Nasdaq rules provided for halting an American Depository Receipt when the security underlying the ADR is halted for regulatory reasons.

The suspension details are as follows:

Company: Shire plc
Issue: American Depositary Shares (ADR)
CUSIP#: 82481R106
Symbol: SHPG
Marketplace Effective Date for Suspension: January 9, 2019
Merger Consideration: $90.99 & 5.034 shs of Takeda Pharmaceutical Company Limited ADRs for each share of Shire plc ADRs held.

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile